[
    [
        {
            "time": "2023-07-29",
            "original_text": "晚间个股传闻",
            "features": {
                "keywords": [
                    "个股",
                    "传闻"
                ],
                "sentiment_score": 0.5,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [],
                "causal_factor": "false",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "晚间个股传闻",
                "Correlation": 3,
                "Sentiment": 4,
                "Importance": 3,
                "Impact": 3,
                "Duration": 2,
                "Entity_Density": 1,
                "Market_Scope": 2,
                "Time_Proximity": 6,
                "Headline_Structure": 5,
                "Source_Recency": 6
            }
        },
        {
            "time": "2023-07-29",
            "original_text": "[互动]华东医药：公司力争今年吲哚布芬销售翻番",
            "features": {
                "keywords": [
                    "华东医药",
                    "吲哚布芬",
                    "销售翻番"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "[互动]华东医药：公司力争今年吲哚布芬销售翻番",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 7,
                "Impact": 7,
                "Duration": 5,
                "Entity_Density": 9,
                "Market_Scope": 3,
                "Time_Proximity": 7,
                "Headline_Structure": 6,
                "Source_Recency": 8
            }
        },
        {
            "time": "2023-07-29",
            "original_text": "[互动]华东医药：参股公司的冷冻祛斑医疗器械F1预计2020年在美国获得正式批准",
            "features": {
                "keywords": [
                    "华东医药",
                    "冷冻祛斑",
                    "医疗器械",
                    "美国批准"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药",
                    "医疗器械"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "[互动]华东医药：参股公司的冷冻祛斑医疗器械F1预计2020年在美国获得正式批准",
                "Correlation": 8,
                "Sentiment": 7,
                "Importance": 6,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 9,
                "Market_Scope": 4,
                "Time_Proximity": 5,
                "Headline_Structure": 6,
                "Source_Recency": 5
            }
        },
        {
            "time": "2023-07-29",
            "original_text": "[互动]华东医药：在研的糖尿病类西格列汀二甲双胍片年底前有望获得生产批文",
            "features": {
                "keywords": [
                    "华东医药",
                    "糖尿病",
                    "西格列汀",
                    "二甲双胍",
                    "生产批文"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "[互动]华东医药：在研的糖尿病类西格列汀二甲双胍片年底前有望获得生产批文",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 9,
                "Market_Scope": 3,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        },
        {
            "time": "2023-07-29",
            "original_text": "长江保护主题指数发布！三峡集团编制 100家优质绿色上市公司入选样本",
            "features": {
                "keywords": [
                    "长江保护",
                    "主题指数",
                    "三峡集团",
                    "绿色上市公司"
                ],
                "sentiment_score": 0.9,
                "policy_related": "true",
                "investment_strategy": "true",
                "sector_focus": [
                    "环保",
                    "绿色经济"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "长江保护主题指数发布！三峡集团编制 100家优质绿色上市公司入选样本",
                "Correlation": 4,
                "Sentiment": 6,
                "Importance": 6,
                "Impact": 5,
                "Duration": 7,
                "Entity_Density": 3,
                "Market_Scope": 9,
                "Time_Proximity": 6,
                "Headline_Structure": 8,
                "Source_Recency": 7
            }
        }
    ]
]